DaVita Labs Grows Through Key Investments
DENVER, May 11, 2011 (BUSINESS WIRE) — DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD) and chronic kidney disease…
Uncategorized
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
DaVita Continues to Lead Industry in Patient Vaccination Rates
DENVER, May 10, 2011 (BUSINESS WIRE) — DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD) and chronic kidney disease…
DaVita Launches Wireless Internet for Dialysis Patients and Physicians
DENVER, May 03, 2011 (BUSINESS WIRE) — DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD) and chronic kidney disease…
DaVita 1st Quarter 2011 Results
DENVER, May 02, 2011 (BUSINESS WIRE) — DaVita Inc. (NYSE:DVA) today announced results for the quarter ended March 31, 2011. Net income attributable to DaVita Inc. for the quarter ended March 31,…
DVA Laboratory Announces New Company Name
DENVER, Apr 29, 2011 (BUSINESS WIRE) — Operating as a division of DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD) and…